NYSE:OSH - Oak Street Health Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $64.67
  • Forecasted Upside: 54.26 %
  • Number of Analysts: 16
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 14 Buy Ratings
  • 0 Strong Buy Ratings
$41.92
▲ +0.34 (0.82%)

This chart shows the closing price for OSH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Oak Street Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for OSH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for OSH

Analyst Price Target is $64.67
▲ +54.26% Upside Potential
This price target is based on 16 analysts offering 12 month price targets for Oak Street Health in the last 3 months. The average price target is $64.67, with a high forecast of $79.00 and a low forecast of $51.00. The average price target represents a 54.26% upside from the last price of $41.92.

This chart shows the closing price for OSH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 16 investment analysts is to buy stock in Oak Street Health.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/26/2020
  • 0 strong buy ratings
  • 7 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/24/2020
  • 0 strong buy ratings
  • 8 buy ratings
  • 2 hold ratings
  • 0 sell ratings
1/22/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/22/2021
  • 0 strong buy ratings
  • 13 buy ratings
  • 2 hold ratings
  • 0 sell ratings
7/21/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 2 hold ratings
  • 0 sell ratings
9/19/2021
  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings
10/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 14 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/13/2021Truist SecuritiesLower Price TargetBuy$72.00 ➝ $55.00Low
10/13/2021TruistLower Price TargetBuy$72.00 ➝ $55.00High
9/27/2021SVB LeerinkInitiated CoverageMarket Perform$51.00Low
9/9/2021CowenInitiated CoverageOutperform$61.00Low
9/8/2021The Goldman Sachs GroupInitiated CoverageBuy$76.00Low
9/7/2021Robert W. BairdInitiated CoverageOutperform$60.00High
8/31/2021Morgan StanleyLower Price TargetOverweight$79.00 ➝ $60.00Low
8/12/2021Raymond JamesLower Price TargetOutperform ➝ Outperform$70.00 ➝ $60.00Low
8/12/2021BarclaysInitiated CoverageOverweight$71.00Low
8/11/2021Canaccord GenuityLower Price TargetBuy$67.00 ➝ $61.00High
5/21/2021Sanford C. BernsteinInitiated CoverageOutperform$79.00Medium
4/20/2021Cantor FitzgeraldInitiated CoverageOverweight$75.00Low
3/15/2021Evercore ISIInitiated CoverageOutperform$75.00High
3/12/2021Morgan StanleyBoost Price TargetOverweight$73.00 ➝ $79.00High
2/24/2021Canaccord GenuityInitiated CoverageBuy$67.00Low
2/17/2021Piper SandlerBoost Price Target$59.00 ➝ $69.00Low
2/12/2021Morgan StanleyBoost Price TargetOverweight$64.00 ➝ $73.00Low
1/28/2021Wolfe ResearchInitiated CoverageOutperform$62.00Low
1/6/2021BTIG ResearchInitiated CoverageNeutralN/A
12/18/2020TruistBoost Price Target$60.00 ➝ $72.00High
12/17/2020Morgan StanleyUpgradeEqual Weight ➝ Overweight$50.00 ➝ $64.00High
12/9/2020Raymond JamesInitiated CoverageOutperform$65.00Low
11/11/2020Piper SandlerReiterated RatingOverweight$54.00 ➝ $59.00High
11/11/2020Robert W. BairdBoost Price TargetOutperform$55.00 ➝ $60.00High
11/11/2020SVB LeerinkBoost Price TargetOutperform$55.00 ➝ $78.00High
9/24/2020SVB LeerinkInitiated CoverageOutperform$55.00High
9/17/2020Piper SandlerReiterated RatingOverweight$54.00High
8/31/2020TruistInitiated CoverageBuy$56.00High
8/31/2020JPMorgan Chase & Co.Initiated CoverageOverweight$52.00High
8/31/2020Robert W. BairdInitiated CoverageOutperform$55.00High
8/31/2020William BlairInitiated CoverageOutperformHigh
8/31/2020Morgan StanleyInitiated CoverageEqual Weight$50.00High
8/31/2020The Goldman Sachs GroupInitiated CoverageBuy$66.00High
8/31/2020Piper SandlerInitiated CoverageOverweight$54.00High
(Data available from 10/19/2016 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/23/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/22/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/21/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/21/2021
  • 4 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/20/2021
  • 2 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
9/19/2021
  • 10 very positive mentions
  • 12 positive mentions
  • 7 negative mentions
  • 0 very negative mentions
10/19/2021

Current Sentiment

  • 10 very positive mentions
  • 12 positive mentions
  • 7 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.
Oak Street Health logo
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Read More

Today's Range

Now: $41.92
Low: $41.23
High: $42.26

50 Day Range

MA: $46.87
Low: $36.18
High: $54.81

52 Week Range

Now: $41.92
Low: $35.67
High: $66.31

Volume

15,536 shs

Average Volume

1,494,764 shs

Market Capitalization

$10.10 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Oak Street Health?

The following Wall Street research analysts have issued reports on Oak Street Health in the last year: Barclays PLC, BTIG Research, Canaccord Genuity, Cantor Fitzgerald, Cowen Inc, Evercore ISI, Morgan Stanley, Piper Sandler, Raymond James, Robert W. Baird, Sanford C. Bernstein, SVB Leerink LLC, The Goldman Sachs Group, Inc., Truist, Truist Securities, Wolfe Research, and Zacks Investment Research.
View the latest analyst ratings for OSH.

What is the current price target for Oak Street Health?

15 Wall Street analysts have set twelve-month price targets for Oak Street Health in the last year. Their average twelve-month price target is $64.67, suggesting a possible upside of 54.3%. Sanford C. Bernstein has the highest price target set, predicting OSH will reach $79.00 in the next twelve months. SVB Leerink LLC has the lowest price target set, forecasting a price of $51.00 for Oak Street Health in the next year.
View the latest price targets for OSH.

What is the current consensus analyst rating for Oak Street Health?

Oak Street Health currently has 2 hold ratings and 14 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OSH will outperform the market and that investors should add to their positions of Oak Street Health.
View the latest ratings for OSH.

How do I contact Oak Street Health's investor relations team?

Oak Street Health's physical mailing address is 30 W. MONROE ST. STE. 1200, CHICAGO IL, 60603. The company's listed phone number is 312-733-9730 and its investor relations email address is [email protected] The official website for Oak Street Health is www.oakstreethealth.com.